BKHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends November 30Also trades as BKHAR, BKHAU
Black Hawk Acquisition Corp
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 6, 2026
$4.03−1.98 (-32.95%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$7.17 (−64.02%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Aug 31, 2026
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- $1.30M
Three years at a glance
Fiscal years 2023 to 2025 and trailing twelve months, USD
Operating income
-$519.49K
Net income
$1.30M-37.7% YoY
Reported periodTrailing twelve months